Experimental Drug Beloranib Helps Patients Lose Up to 24 Pounds

Experimental drug beloranib helps patients lose up to 24 pounds
An experimental obesity drug, which unlike other therapies targets the body and not the mind, helped patients lose up to 24 pounds, or about 11% of their body weight, in a clinical trial, its developer said on Friday. The injectable drug, beloranib … Read more on Chatham Daily News

Neuropsychoanalysis Association to host conference on depression
This full day program will be an interdisciplinary event focusing on pioneering work in biological psychiatry, basic neuroscience and other fields aimed at discovering new treatments for depression, including what have we learned so far, future … Read more on News-Medical.net